Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT: Acetylcysteine for Contrast-induced Nephropathy
NCT00736866Phase 3Completed
- Sponsor
- HCor
- Start
- Aug 2008
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine in contrast-induced nephropathy (CIN), sponsored by HCor. Started Aug 2008; status: completed.
02
Drugs
acetylcysteine
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT00736866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00736866.